Atlas Venture Fund VII L P
10% Owner | 2018-02-09 17:41:14 | 2,583,203
0 | 2,583,203 | Form 13G |
Danish Biotech SPV I P/S
Omega Fund IV L.P.
10% Owner | 2017-02-14 11:18:03 | 2,575,352
0 | 2,575,352 | Form 13G |
FORMELA JEAN FRANCOIS
Director
10% Owner | 2014-02-12 15:01:22 | 0
2,460,949 | 2,460,949 | Form 4 |
SEGERROS ANDREAS Rutger
Director
10% Owner | 2014-02-12 17:42:59 | 0
2,014,553 | 2,014,553 | Form 4 |
SUNSTONE LIFE SCIENCE VENTURES FUND II K/S
10% Owner | 2014-02-24 15:20:46 | 1,859,615
0 | 1,859,615 | Form 13G |
Index Venture Associates III Ltd
Index Ventures III (Jersey) L.P.
Index Ventures III (Delaware) L.P.
Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P.
Yucca (Jersey) SLP
INDEX VENTURES LIFE VI (JERSEY) L.P.
10% Owner | 2018-02-14 14:37:31 | 1,386,602
0 | 1,386,602 | Form 13G |
Riva Ridge Capital Management LP
RIVA RIDGE GP LLC
Golden Stephen H
Shim James
10% Owner | 2020-02-12 17:15:20 | 938,661
0 | 938,661 | Form 13G |
Musial Stan
Chief Financial Officer | 2018-06-15 17:31:37 | 347,407
0 | 347,407 | Form 4 |
AGUIAR-LUCANDER RENEE
Director | 2014-02-12 18:11:13 | 0
314,574 | 314,574 | Form 4 |
Wilkins H Jeffrey
SVP and Chief Medical Officer | 2019-07-01 21:13:55 | 190,000
0 | 190,000 | Form 4 |
Shea Patrick M
Chief Commercial Officer | 2019-03-28 16:01:21 | 90,000
0 | 90,000 | Form 4 |
Dayno Jeffrey M.
Chief Medical Officer | 2017-06-12 16:40:43 | 80,000
0 | 80,000 | Form 4 |
Radie Robert S
Principal Financial Officer | 2020-01-02 19:43:49 | 76,915
0 | 76,915 | Form 4 |
LINDHARDT KARSTEN
VP, Research & Development | 2016-07-06 17:57:48 | 40,000
0 | 40,000 | Form 4 |
Melloy Deanne F.
Chief Commercial Officer | 2016-04-06 16:03:05 | 33,420
0 | 33,420 | Form 4 |
VARKI PAUL
SVP, GC & Chief Compliance Off | 2017-07-06 16:47:14 | 29,514
0 | 29,514 | Form 4 |
KOZLOV ANDREY
Director | 2014-02-05 15:49:43 | 0
0 | 0 | Form 3 |
McInnis Joe
Director | 2020-05-21 16:33:31 | 0
0 | 0 | Form 4 |
Strobeck Mark
Chief Operating Officer | 2020-05-21 16:33:01 | 0
0 | 0 | Form 4 |
Walbert Timothy P
Director | 2020-05-21 16:32:30 | 0
0 | 0 | Form 4 |
Smiley Andrea Heslin
Director | 2020-05-21 16:32:15 | 0
0 | 0 | Form 4 |
Phillips Gary M.
Director | 2020-05-21 16:31:45 | 0
0 | 0 | Form 4 |
Pauls Matthew
Director | 2020-05-21 16:31:30 | 0
0 | 0 | Form 4 |
SMITH TODD N
President and CEO | 2020-05-21 16:31:15 | 0
0 | 0 | Form 4 |
TIMMINS MEGAN C.
General Counsel | 2020-05-21 16:30:46 | 0
0 | 0 | Form 4 |
CR Group L.P.
CRG Partners III - Parallel Fund B (Cayman) L.P.
CRG Partners III - Parallel Fund (A) L.P.
CRG Partners III (Cayman) Lev AIV I L.P.
CRG Partners III (Cayman) Unlev AIV I L.P.
CRG Partners III L.P.
Loan Security Holdings I LLC
10% Owner | 2020-05-22 16:07:17 | 0
0 | 0 | Form 4 |
Capital Royalty L.P.
Iroko Pharmaceuticals Inc.
Iroko Properties Inc.
CRG Partners III (Cayman) Lev AIV I L.P.
CRG Partners III (Cayman) Unlev AIV I L.P.
CRG Partners III L.P.
Loan Security Holdings I LLC
CRG Partners III - Parallel Fund B (Cayman) L.P.
CRG Partners III - Parallel Fund (A) L.P.
10% Owner | 2020-05-22 16:07:08 | 0
0 | 0 | Form 13D |
Duster Luke
Director | 2019-06-24 18:11:43 | 0
0 | 0 | Form 4 |
Holmes Todd
Director | 2019-02-11 17:36:17 | 0
0 | 0 | Form 3 |
ROCHE ROBERT P JR
Director | 2019-02-04 20:12:10 | 0
0 | 0 | Form 4 |
NICOLAIDES NICHOLAS C
Director | 2019-02-04 20:11:56 | 0
0 | 0 | Form 4 |
WEAVER GREGORY L
Director | 2019-02-04 20:10:42 | 0
0 | 0 | Form 4 |
OSBORN JOHN E
Director | 2019-02-04 20:10:27 | 0
0 | 0 | Form 4 |
Hochberg Elaine
Director | 2019-02-04 20:10:10 | 0
0 | 0 | Form 4 |
Varian John
Director | 2019-02-04 20:09:19 | 0
0 | 0 | Form 4 |
CARLIN BARBARA
Chief Accounting Officer | 2019-02-04 18:32:35 | 0
0 | 0 | Form 4 |